Globus Starts Slow But Reaffirms Guidance for 2022
The company grew in the low single digits for 1Q22 due to a tough comparison and a stagnant robotic sales...
The company grew in the low single digits for 1Q22 due to a tough comparison and a stagnant robotic sales...
The company grew over 60% in 1Q21 as recent acquisitions added momentum to Enovis' already impressive share gains....
Accelus’ FlareHawk portfolio of spinal fusion cages is now available in a larger footprint with titanium at the bony interface....
Velocity Bump is reportedly the first manual knee positioner operated completely outside the sterile field....
Under the 5-year exclusive agreement, AMI Medical Technologies will distribute, promote and sell Bioretec's bioresorbable Activa implants....
The no-rinse solution demonstrated persistent efficacy against both planktonic bacteria and bacterial biofilms in total hip replacement....
The company grew over 20% in the first quarter of 2022 as it wins over new surgeons and more exclusive...
The company grew more than 60% in the first quarter of 2022 as it continues expanding its portfolio and geographic...
The company declined in the mid-teens in 1Q22 as it exited unprofitable geographies and optimized its portfolio for longer term...
The company grew less than 1% in the first quarter of 2022 as macro environment pressures disrupted both January and...
Login
Register for a free account
As a guest member you get access to more articles and videos every month.